All data are based on the daily closing price as of December 26, 2025
s
Shin Nippon Biomedical Laboratories
2395.TSE
11.05 USD
-0.16
-1.43%
Overview
Last close
11.05 usd
Market cap
460.18M usd
52 week high
12.51 usd
52 week low
6.66 usd
Target price
15.59 usd
Valuation
P/E
14.1069
Forward P/E
N/A
Price/Sales
2.0761
Price/Book Value
1.9005
Enterprise Value
629.63M usd
EV/Revenue
2.8423
EV/EBITDA
11.1347
Key financials
Revenue TTM
221.51M usd
Gross Profit TTM
109.34M usd
EBITDA TTM
38.25M usd
Earnings per Share
0.71 usd
Dividend
0.19 usd
Total assets
615.35M usd
Net debt
180.78M usd
About
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels. In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.